| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |